BioCentury
ARTICLE | Clinical News

Atu027: Additional Phase IIa data

June 8, 2015 7:00 AM UTC

A post hoc analysis of the subgroup of 19 patients with metastatic pancreatic adenocarcinoma in the Phase IIa portion of the open-label, German Phase Ib/IIa Atu027-I-02 trial showed that twice-weekly ...